A breaker bar is one of those specialty tools that every home mechanic wishes they had sooner or later. It's useful for encouraging stuck nuts and bolts to turn as a last-ditch effort to remove them ...

Children who have smartphones by age 12 are at an increased risk for depression, obesity, and lack of sleep, according to a new study published Monday in the journal Pediatrics. The researchers looked ...

On 1 December 2025, the World Health Organization released an important new guideline recognising obesity as a chronic, relapsing disease, and for the first time ever, showed support in the use of GLP ...

Dec. 1 (UPI) --A new study by the American Academy of Pediatrics finds preteens who own smartphones and use them regularly are at greater risk of depression, obesity and insufficient sleep. The ...

The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The disease now affects more than 1 billion people worldwide and is tied to 3.7 ...

Dec 1 (Reuters) - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the ...

The earlier the age a child received a smartphone the greater the health risk. Children who have smartphones by age 12 are at higher risk of lack of sleep, obesity and depression, according to a new ...

Objective: To identify clinical variables causally associated with hair cortisol concentration (HCC) in dogs with obesity using a Bayesian analysis. Study design: A retrospective analysis of clinical ...

View post: The 7 Best Places To Ski in January 2026 Bar up? Or bar down? Every skier chooses the latter, right? Not quite. Regionally and from skier-to-skier, there is no consensus on using chairlift ...

This article and associated images are based on a poster originally authored by Dhruv Sunil Choudhary and presented at ELRIG Drug Discovery 2025 in affiliation with the University of Westminster. This ...

Prescriptions for GLP-1 receptor agonists in cancer patients have increased despite lack of clinical guidance. The overall prescription rate was low (4.1%) but increased significantly over 4 years.